Immediate Impact
62 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Cancer stem cells: advances in knowledge and implications for cancer therapy
2024 Standout
Works of Ruben Reyes being referenced
Phase 1 dose-escalation study of IV ixazomib, an investigational proteasome inhibitor, in patients with relapsed/refractory lymphoma
2014
Preclinical and Phase I Results of Decitabine in Combination with Midostaurin (PKC 412) for Newly Diagnosed Elderly or Relapsed/Refractory Adult Patients with Acute Myeloid Leukemia
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ruben Reyes | 82 | 27 | 85 | 39 | 15 | 154 | |
| H. Kreipe | 42 | 18 | 124 | 48 | 13 | 172 | |
| Cecilia Arana Yi | 78 | 22 | 97 | 70 | 20 | 201 | |
| Salvatore Casciaro | 110 | 26 | 82 | 66 | 13 | 181 | |
| Tadashi Miike | 93 | 14 | 47 | 28 | 21 | 156 | |
| Kristina M. Knapp | 81 | 22 | 73 | 47 | 13 | 154 | |
| Kota Fukumoto | 74 | 59 | 98 | 37 | 20 | 184 | |
| Jasleen K. Randhawa | 92 | 18 | 138 | 64 | 14 | 173 | |
| Marcin M. Machnicki | 55 | 25 | 28 | 32 | 25 | 139 | |
| Veronica Guerra | 113 | 16 | 114 | 34 | 15 | 200 | |
| Yusuke Isshiki | 93 | 20 | 63 | 26 | 20 | 150 |
All Works
Loading papers...